Episode 078: Management of relapsed diffuse large B-cell lymphoma (DLBCL) - Part 2
The Fellow on Call: The Heme/Onc Podcast
00:00
Exploring Alternative Therapies for Relapsed DLBCL
This chapter delves into alternative treatment options for relapsed diffuse large B-cell lymphoma, particularly the therapies loncastuximab and tafasitamab plus lenalidomide. The speakers discuss clinical trial results, response rates, and the implications of prior treatments on patient eligibility.
Transcript
Play full episode
